» Articles » PMID: 34550970

Implementation of Artificial Intelligence Algorithms for Melanoma Screening in a Primary Care Setting

Abstract

Skin cancer is currently the most common type of cancer among Caucasians. The increase in life expectancy, along with new diagnostic tools and treatments for skin cancer, has resulted in unprecedented changes in patient care and has generated a great burden on healthcare systems. Early detection of skin tumors is expected to reduce this burden. Artificial intelligence (AI) algorithms that support skin cancer diagnoses have been shown to perform at least as well as dermatologists' diagnoses. Recognizing the need for clinically and economically efficient means of diagnosing skin cancers at early stages in the primary care attention, we developed an efficient computer-aided diagnosis (CAD) system to be used by primary care physicians (PCP). Additionally, we developed a smartphone application with a protocol for data acquisition (i.e., photographs, demographic data and short clinical histories) and AI algorithms for clinical and dermoscopic image classification. For each lesion analyzed, a report is generated, showing the image of the suspected lesion and its respective Heat Map; the predicted probability of the suspected lesion being melanoma or malignant; the probable diagnosis based on that probability; and a suggestion on how the lesion should be managed. The accuracy of the dermoscopy model for melanoma was 89.3%, and for the clinical model, 84.7% with 0.91 and 0.89 sensitivity and 0.89 and 0.83 specificity, respectively. Both models achieved an area under the curve (AUC) above 0.9. Our CAD system can screen skin cancers to guide lesion management by PCPs, especially in the contexts where the access to the dermatologist can be difficult or time consuming. Its use can enable risk stratification of lesions and/or patients and dramatically improve timely access to specialist care for those requiring urgent attention.

Citing Articles

Artificial Intelligence-Aided Diagnosis System for the Detection and Classification of Private-Part Skin Diseases: Decision Analytical Modeling Study.

Wang W, Chen X, Xu L, Huang K, Zhao S, Wang Y J Med Internet Res. 2024; 26():e52914.

PMID: 39729353 PMC: 11724214. DOI: 10.2196/52914.


Integrating artificial intelligence with smartphone-based imaging for cancer detection in vivo.

Song B, Liang R Biosens Bioelectron. 2024; 271:116982.

PMID: 39616900 PMC: 11789447. DOI: 10.1016/j.bios.2024.116982.


Skin Cancer Image Classification Using Artificial Intelligence Strategies: A Systematic Review.

Vardasca R, Mendes J, Magalhaes C J Imaging. 2024; 10(11).

PMID: 39590729 PMC: 11595075. DOI: 10.3390/jimaging10110265.


Pilot deployment of a cloud-based universal medical image repository in a large public health system: A protocol study.

Pacheco V, Paiva J, Furriel B, Santos P, Ferreira Junior J, Reis M PLoS One. 2024; 19(8):e0307022.

PMID: 39208265 PMC: 11361589. DOI: 10.1371/journal.pone.0307022.


The Use of Artificial Intelligence for Skin Disease Diagnosis in Primary Care Settings: A Systematic Review.

Escale-Besa A, Vidal-Alaball J, Miro Catalina Q, Gracia V, Marin-Gomez F, Fuster-Casanovas A Healthcare (Basel). 2024; 12(12).

PMID: 38921305 PMC: 11202856. DOI: 10.3390/healthcare12121192.


References
1.
Rigel D, Friedman R, Kopf A . Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol. 1996; 35(6):1012-3. DOI: 10.1016/s0190-9622(96)90139-5. View

2.
Mirza F, Yumeen S, Walter F . The epidemiology of malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK from 2004 to 2014: a population-based cohort analysis using the Clinical Practice Research Datalink. Br J Dermatol. 2020; 184(2):365-367. DOI: 10.1111/bjd.19542. View

3.
Garbe C, Peris K, Soura E, Forsea A, Hauschild A, Arenbergerova M . The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force. J Eur Acad Dermatol Venereol. 2020; 34(10):2183-2197. DOI: 10.1111/jdv.16849. View

4.
Apalla Z, Nashan D, Weller R, Castellsague X . Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches. Dermatol Ther (Heidelb). 2017; 7(Suppl 1):5-19. PMC: 5289116. DOI: 10.1007/s13555-016-0165-y. View

5.
Tschandl P, Rinner C, Apalla Z, Argenziano G, Codella N, Halpern A . Human-computer collaboration for skin cancer recognition. Nat Med. 2020; 26(8):1229-1234. DOI: 10.1038/s41591-020-0942-0. View